Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting PRMT1 activity. Methods of using the compounds for treating PRMT1-mediated disorders are also described.
本文描述了式(I)的化合物,其药用盐以及药物组成物。本文描述的化合物可用于抑制PR
MT1活性。还描述了使用这些化合物治疗PR
MT1介导的疾病的方法。